Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Regulation FD disclosure
  8. 4 Grant or award Chief Operating Officer acquired 73,000 shares (grant or award)
  9. 4 Grant or award Chief Legal Officer & Corp Sec acquired 91,000 shares (grant or award)
  10. 4 Grant or award Chief Medical Officer acquired 94,000 shares (grant or award)
  11. 4 Grant or award CFO & Chief Business Officer acquired 106,000 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 401,000 shares (grant or award)
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 8-K Event Material agreement
  18. 4 Planned sale Director sold 41,949 shares at an average $6.49 ($272,334)
  19. 144 Insider Sale of Securities
  20. 10-Q Report Quarterly Report

Page 11 of 19 · 365 filings